Fig. 1From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysisExpression analysis of NEAT1 in the gastric cancer samples and breast cancer samples, compared to control samples, based on the ENCORI online software. This analysis showed that NEAT1 had a significant up-regulation in the GC samples and a significantly low expression in the BC samples Back to article page